Wyeth Duract Withdrawn After Continued Reactions To Long-Term Use
Executive Summary
Further efforts to limit Wyeth-Ayerst's Duract to short-term use "would not be practical or effective," FDA said in explaining the company's June 22 market withdrawal of the non-steroidal anti-inflammatory drug bromfenac.